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A new BODIPY (BDP 1) bearing a dimethylaminopropoxy group attached to a phenylene 
unit was synthesized. This compound was brominated to obtain the halogenated analog BDP 2, 
which was designed to enhance the photodynamic effect of BODIPY to kill bacteria without an 
intrinsic cationic charge. The basic amino group located at the end of the propoxy bridge can 
acquire positive charge by protonation in an aqueous medium, increasing the binding to bacterial 
cells. Interaction and photokilling activity mediated by these compounds was evaluated in 
Staphylococcus aureus and Escherichia coli. BDP 1 and BDP 2 were rapidly bound to bacterial 
cells, showing bioimages with green emission. Complete elimination of S. aureus was detected 
when cells were incubated with 1 μM BDP 2 and irradiated for 5 min. Comparable 
photoinactivation was obtained with E. coli, after an irradiation of 30 min. Furthermore, BDP 2 was 
effective to kill bacteria at very low concentration (0.5 M). Thus, BDP 1 showed mainly 
interesting properties as a fluorophore, whereas BDP 2 was highly effective photosensitizer as a 
broad-spectrum antibacterial agent. 
 













 The increased resistance of bacteria to antibiotics for clinical use makes it difficult to cure 
many infectious diseases [1]. The overuse of antimicrobials in hospitals as a prophylactic measure 
in surgical operations, the tendency to use broad-spectrum antibiotics, self-medication, inadequate 
prescription and non-compliance with treatments by patients are some of the factors responsible for 
mutagenic changes in these pathogenic microorganisms. Also, the resistance can be increased by 
the use of antibiotics for multiple purposes in the husbandry of livestock [2]. The Gram-positive 
bacteria Staphylococcus aureus has been recognized as one of the pathogens with the highest 
epidemiological resistance found in hospital treatments [3]. Consequently, this microorganism 
represents a serious threat to medicine in health care. Also noteworthy is the worldwide presence of 
Gram-negative bacteria resistant to multiple drugs, such as Escherichia coli to different generations 
of antibiotics [4]. A significant number of serious nosocomial infections are caused by E. coli [5]. 
Furthermore, this bacterium is part of a significant reservoir in animals, as well as in the 
environment [6]. Despite the constant expansion of antibiotic resistance, the number of new 
antimicrobial agents to be used as medications has been quite limited in recent years. Therefore, the 
development of substitute strategies is required to ensure that bacterial diseases continue treatable 
with accessible therapies [7]. One of the therapies that have been proposed to eradicate resistant 
microorganisms is known as photodynamic inactivation (PDI) [8]. This is a promising method that 
is based on the formation of reactive oxygen species (ROS) by a photosensitizer (PS), which was 
previously incorporated into microbial cells. After excitation of the PS with appropriate light, two 
photodynamic pathways can occur in PDI [9]. Type I process involves the PS excited triplet state 
that reacts with different substrates by electron or proton transfer, leading to the formation of free 





)) to produce ROS, such as hydroxyl radical (HO
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hydrogen peroxide (H2O2). On the other hand, the PS excited triplet state can form singlet 
molecular oxygen, O2(
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mechanisms can occur independently or combined depending on the PS and the medium. Either 
way, ROS is produced and react rapidly with various biological components inducing microbial 
cells death. 
In the last decade, numerous PSs have been studied and evaluated as phototherapeutic 
compounds for the PDI of microorganisms. However, there are relatively few structures derived 
from 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY) proposed as PSs for the 
photoinactivation of microorganisms [11]. The synthesis of these derivatives offers a wide range of 
alternatives to attach different substituents, as well as the versatility to produce modifications in the 
periphery of the s-indacene ring [12]. This family of compounds has very interesting spectroscopic 
properties, including a high molar absorption coefficient and fluorescence emission in the central 
region of the visible spectrum. For this reason, together with their good photochemical stability, 
these compounds have originally been proposed as fluorophores for bioimaging [13]. BODIPY core 
has been subsequently improved to decrease fluorescence emission and increase the formation of 
excited triplet state for applications in photodynamic therapy [14]. 
The aim of this investigation was to synthesize new BODIPY derivatives containing a 
dimethylaminopropoxy group attached to the phenylene unit. BDP 1 was designed to act primarily 
as a fluorophore, while brominated BDP 2 as a potential phototherapeutic agent for the inactivation 
of bacteria. In previous studies, a BODIPY substituted by trimethylaminopropoxy group with 
intrinsic positive charges in combination with potassium iodide was effective as a broad-spectrum 
antimicrobial PS [15,16]. Furthermore, porphyrins and chlorins showed that the presence of 
dimethylaminopropoxy groups on the periphery of the macrocycle turns these compounds into 
effective PSs to inactivate microorganisms [17,18]. This substituent bears a basic amine group that 
can acquire positive charges in aqueous media, improving the interaction of PS with the cell 
envelope. In addition, spectroscopic characteristics and photodynamic properties of these BODIPYs 

















detect ROS. Studies in biological cultures were carried out in a typical Gram-positive bacteria S. 
aureus and Gram-negative bacteria E. coli. These investigations were focused on the ability of these 
compounds for imaging fluorescent bacterial cells and photokill pathogens. 
 
2. Materials and methods 
2.1. Synthesis of BODIPY derivatives 
8-Acetoxymethyl-1,3,5,7-tetramethyl pyrromethene fluoroborate (H2B-OAc) and 8-
acetoxymethyl-2,6-dibromo-1,3,5,7-tetramethyl pyrromethene fluoroborate (Br2B-OAc) were 
synthesized as previously reported [19]. 
4,4-Difluoro-8-[4-(3-(N,N-dimethylamino))propoxiphenyl]-1,3,5,7-tetramethyl-4-bora-
3a,4a-diaza-s-indacene (BDP 1). 2,4-Dimethylpyrrole (500 µL, 4.85 mmol) and 4-(3-(N,N-
dimethylamino)propoxy)benzaldehyde (400 µL, 1.99 mmol) were treated with trifluoroacetic acid 
(TFA, 30 µL, 0.39 mmol) in 75 mL of dichloromethane (DCM). The solution was deoxygenated 
with argon and stirred overnight at room temperature. Then, 2,3-dichloro-5,6-dicyano-1,4-
benzoquinone (DDQ, 461 mg, 2.03 mmol) in 25 mL of DCM was added drop by drop in the 
reaction flask and the mixture was kept under stirring for 6 h. After that, it was placed in a cold bath 
to decrease the temperature to about -1° C and an excess of triethylamine (TEA, 5 mL, 35.9 mmol) 
was incorporated and boron trifluoride diethyl etherate (BF3
.
OEt2, 5 mL, 40.5 mmol) was added 
after 15 min and the solution was stirred for 12 h. The mixture was washed with water and the 
organic phase was dried over Na2SO4. The crude product was obtained by solvent evaporation 
under reduced pressure. The product was purified by flash column chromatography (silica gel) 
using DCM:n-hexane (80:20) with 1% TEA as eluent provided 127 mg (14%) of BDP 1. TLC 
(DCM: TEA 1%) Rf = 0.54. 
1
HNMR (CDCl3, TMS)  [ppm] 1.49 (s, 6H), 1.96 (m, 2H), 2.30 (s, 
6H, -N(CH3)3), 2.51 (t, 2H, J = 6.8 Hz, -CH2-N), 2.55 (s, 6H), 4.11 (t, 2H, J = 6.1 Hz, -CH2-O), 
5.97 (s, 2H, pyrrole), 7.00 (d, 2H, J = 8.7 Hz, Ar), 7.17 (d, 2H, J = 8.7 Hz, Ar). ESI-MS [m/z] 
426.2521 (425.2528 calculated for (M+H)
+













tetramethyl-4-bora-3a,4a-diaza-s-indacene (BDP 2). A mixture of BDP 1 (28 mg, 0.065 mmol) 
and N-bromosuccinimide (NBS, 25 mg, 0.14 mmol) in 3 mL of (trifluoromethyl)benzene (TFB) 
was stirred for 25 min at room temperature. The organic solution was washed with water and dried 
over Na2SO4. Finally, TFB was removed by distillation under reduced pressure. Flash column 
chromatography (silica gel) using DCM:n-hexane (80:20) with 1% TEA as eluent afforded 37 mg 
(98%) of BDP 2. TLC (DCM:TEA 1%) Rf = 0.50. 
1
HNMR (CDCl3, TMS)  [ppm] 1.43 (s, 6H), 
1.99 (m, 6H), 2.31 (s, 6H, -N(CH3)3), 2.52 (t, 2H, J = 6.8 Hz, -CH2-N), 2.60 (s, 6H), 4.12 (t, 2H, J = 
6,1 Hz, -CH2-O), 7.01 (d, 2H, J = 8.8 Hz, Ar), 7.16 (d, 2H, J = 8.8 Hz, Ar). ESI-MS [m/z] 582.0741 
(582.0738 calculated for (M+H)
+
, M = C24H28BBr2F2N3O). 
 
2.2. Spectroscopic measurements 
UV-visible absorption and fluorescence studies were performed as reported [15]. Spectral 
determinations were achieved using 1 cm path length quartz cells in acetonitrile (ACN) at room 
temperature. To obtain the emission spectra, absorbances (<0.05) of the samples were matched at 
the excitation wavelength (λexc = 480 nm). The areas of the fluorescence intensity vs. wavelength 
were integrated in the range of 485-800 nm. The fluorescence quantum yield (F) of BODIPYs 
were calculated taking into account the area below the corrected emission spectrum with that of 
H2B-OAc, which was as a reference (F = 0.87 in ACN) [19]. 
 
2.3. Computational details 
All density functional theory (DFT) computations were attained with a Gaussian 09 package 
(Gaussian, Wallingford, CT) using the B3LYP functional coupled with the 6-31G(d) basis set [20]. 
Geometries for the molecules were fully optimized. Conformational searches were achieved to 
locate the minimum-energy conformers of the molecules. Originally, numerous geometries were 












MMFF force field and then subjected to PM6 optimization. All molecular structures were 
consecutively re-optimized at the B3LYP/6- 31 G(d) levels of theory. Optimized structures in the 
excited singlet state were obtained by geometry optimizations performed using the TD-DFT 
method. Molecular electrostatic potential (ESP) surfaces of the optimized structures were visualized 
using GaussView Software Version 6.0, with an iso value of 0.0004 e/au
3
. The colors of the 
potential surfaces were selected to obtain the maximum contrast between the relative locations of 
the positive (blue) and negative (red) charges. 
 
2.4. Determination of O2(
1g) formation 
DMA (35 µM) and BODIPY (absorbance 0.1 at 506 nm) in 2 mL ACN were irradiated with 
light at λirr = 506  6 nm under aerobic conditions. Photooxidation of DMA was measured by the 
decrease of the absorbance (A) at λ max=378 nm [15]. Fit of the semilogarithmic plot of ln A0/A vs. 
time using linear least-squares was used to calculated the observed rate constants (kobs) values. 
Under the same experimental conditions, quantum yields of O2(
1
g) production () in ACN were 
determined by comparing the kobs for the corresponding BODIPY with that of Br2B-OAc, which 
was used as a reference ( = 0.79 in ACN) [19]. 
 
2.5. Photoreduction of nitrotetrazolium blue (NBT) 
Aerobic solutions of NBT (0.2 mM), β-NADH (0.5 mM) and BODIPY (absorbance 0.1 at 
506 nm) in 2 mL of DMF/1% water were exposed with light at λirr = 506  6 nm. The 
decomposition of NBT was monitored by increasing absorbance at λ = 560 nm due to the formation 
of diformazan [20]. Controls were carried out in the absence of each of the components. 
 
2.6. Bacterial strains and cultures 
S. aureus ATCC 25923 and E. coli EC7 strains were used in this investigation [16,17]. 
Cultivation and handling of bacteria to yield ~10
8












buffered saline (PBS, pH = 7.0) were attained as reported (see supporting information) [16]. Viable 
bacteria were calculated by spread plate method using serial dilutions 10-fold in PBS after an 
incubation of the culture for 24 h at 37 °C in the dark. 
 
2.7. Binding of BODIPYs to bacterial cells 
Bacterial cells (2 mL, ∼108 CFU/mL) in Pyrex culture tubes (13 × 100 mm) were treated 
with BDP 1 or BDP 2 in the dark at 37 °C, varying the PS concentrations (0.5 and 1.0 μM) and 
incubation times (2, 5, 15 and 30 min). The BODIPYs were added to the cultures from a stock 
solution (0.5 mM) in ACN. In each experiment, 1 mL of the cell suspension was placed in an 
Eppendorf tube. After that, cells were harvested by centrifugation for 1 min at 14,000 rpm and the 
pellets were re-suspended in 3 mL of 2% aqueous sodium dodecyl sulfate (SDS). Samples were 
kept overnight at 4 °C in dark and then sonicated for 15 min. Fluorescence intensity of each 
BODIPY in the supernatant was measured by spectrofluorimetry (λexc = 480 nm, λem = 510 nm for 
BDP 1 and λexc = 480 nm, λem = 536 nm for BDP 2, Figure S1 and S2). The concentration of the PS 
in the solution was determined using a calibration curve, which was obtained using standard 
solutions (0.005-0.2 μM) of the BODIPY in 2% SDS. The amount of BODIPY bound to the cells 
was calculated considering the total number of cells [16]. 
 
2.8. Fluorescence images of attached bacterial cells 
Fluorescence microscopy images were completed using the procedure reported [21,22]. 
Bacterial suspension (100 μL) was incubated in a chamber, formed by a polymeric cylinder glue to 
a coverslip, for 30 min at 37 ºC to allow the cells to anchor to the glass surface. Then, the chamber 
was washed with PBS to remove bacterial cells that were not attached to the glass. After that, 1 M 
BOBIPY in 200 μL PBS was added into the chamber and kept in the dark for 30 min in dark at 37 
ºC. Cells were washed with PBS to remove the PS that was not bound to cells and fluorescence 













2.9. Photosensitized inactivation of bacterial cells 
Bacteria in PBS (1 mL, ~10
8
 CFU/mL) were treated with each BODIPY using different 
concentrations (0.5 and 1.0 μM for S. aureus and 0.5, 1.0 and 5.0 μM for E. coli) for 30 min in the 
dark at 37 °C [16]. Then, the cell suspensions were irradiated with visible light (70 mW/cm
2
) in 96-
well microtiter plate for different periods (2, 5 and 15 min for S. aureus and 5, 15 and 30 min for E. 
coli). The amount of viable bacterial cells was calculated as described above. In all biological tests, 
controls and statistical analysis with bacterial cells were performed as reported (see supporting 
information) [16]. 
 
3. Results and discussion 
3.1. Synthesis of BODIPYs 
The synthetic approaches to obtain the BODIPYs are illustrated in Scheme 1. BDP 1 was 
synthesized from 4-[3-(N,N-dimethylamino)propoxy]benzaldehyde and 2,4-dimethylpyrrole 
catalyzed by TFA in DCM. In the first stage, this reaction yielded the corresponding 
dipyrromethane substituted with a dimethylaminopropoxyfenil group at the central position of s-
indacene ring (meso position).  
The dipyrromethane was aromatized with DDQ to produce its counterpart dipyrromethene, 
which was changed to a BODIPY core by complexation with a difluoroboryl unit through reaction 
with BF3
.
OEt2 using TEA as a basic catalyst [23]. For the preparation of the brominated derivative 
BDP 2, an aromatic electrophilic substitution was carried out at positions 2 and 6 of BDP 1 with 
NBS in TFT (Scheme 1). The use of NBS in fluorinated solvents (TFT) drastically reduces the 
reaction time of halogenations giving excellent yields and regioselectivity to positions 2 and 6 of 
BODIPY core [21,24]. Both products were purified by chromatography on silica gel, yielding 14% 












BDP 1 and BDP 2 do not have an intrinsic positive charge on their phenylene substituent. 
Nevertheless, these BODIPYs contain in the meso position a basic amino group that act as 
precursors of positive charges on the periphery of the chromophore. Considering the basicity of the 
aliphatic amine groups (3-N,N-dimethylaminepropanol, pKa = 9.51) protonation of this substituent 
is expected in PBS [25]. Furthermore, the formed cationic center is isolated from the BODIPY 
structure by an aliphatic chain. Optimized structure and ESP surfaces of BDP 1 and BDP 2 were 
compared with those of their protonated forms as shown in Figure 1. From this analysis, spatial 
regions in the molecular structure were determined in which the molecular electrostatic potential 
was negative and positive. This allowed us to visualize the charged regions of each molecule and 
the distribution on the structure of the BODIPY. As can be seen, the cationic charge does not have a 
significant effect on the electronic density of the BODIPY nucleus. Therefore, this isolation of the 
cationic group allows to retain the spectroscopic and photodynamic properties of PS. In addition, 
the aliphatic spacer in the aryl substituent provides higher mobility of the charged group, which can 
facilitate the binding of the PS to bacterial cells increasing its PDI activity [17,18]. 
 
3.2. Absorption and fluorescence spectroscopic properties 
 The UV-visible absorption spectra of BDP 1 and BDP 2 in ACN are shown in Figure 2A. 
The spectra of these compounds presented the characteristic bands of BODIPYs with similar 
structures [26]. The spectroscopic properties of these BODIPYs are given in Table 1. The main 
band of the non-halogenated dye was centered at ~ 500 nm. This band corresponds to the vibratory 
band 0-0 of the transition to the first excited state (S0 → S1) [15]. A small characteristic shoulder at 
a shorter wavelength centered around 475 nm was observed, which was assigned to the 0-1 
vibrational band of the same electronic transition. In addition, a second small band displaced to blue 
(~ 370 nm) was detected that was attributed to the transition S0 → S2. In BDP 2, the presence of 
bromine atoms at positions 2 and 6 of BODIPY core produced a bathochromic shift of 25 nm 












bromination of BODIPY derivatives [27]. This effect was assigned to the resonance donating effect 
of bromine atoms [19]. In both cases, sharp absorption bands were obtained indicating that these 
compounds are mainly non-aggregated in ACN. 
Fluorescence emission spectra of BDP 1 and BDP 2 were performed in ACN (Figure 2B). 
BDP 1 presented a band around 506 nm that is characteristic for similar BODIPYs, while BDP 2 
showed a fluorescence peak at 537 nm [27]. In this structure, the substitution with bromine atoms 
resulted in a bathochromic change of 31 nm in the emission spectra due to the effect of resonance 
donation of the heavy atoms. These emission bands were assigned to the 0-0 vibrational band of the 
S1→S0 transitions [15,28]. Furthermore, the energy levels of the singlet excited state (Es) of these 
BODIPYs were determined considering the energy of the 0-0 electronic transitions (Table 1) [19]. 
Moreover, Stokes shifts of 9 nm for BDP 1 and 15 nm for BDP 2 were estimated from the 
difference between the positions of the maxima of the absorption and emission bands for the 
electronic transition 0-0. These small Stokes shifts show that the BODIPY structure does not 
change significantly after excitation [29]. Values of F for BDP 1 and BDP 2 were determined in 
ACN (Table 1). A higher F was found for BDP 1, which agrees with those previously reported for 
similar BODIPYs [27]. A 3.5-fold drop in F values was noted when comparing BDP 1 and BDP 2. 
The weak emission of BDP 2 was attributed to the substitution with bromine atoms, as found for 
this type of BODIPYs [19,27]. In a previous work, we have shown that the presence of bromine 
atoms at positions 2 and 6 of the s-indacene ring produces a 4-6-fold reduction in the fluorescence 
lifetimes due to the heavy atom effect showing a triplet state lifetime of ~40 µs [19]. This effect 
enhances spin-orbit coupling facilitating ISC and increasing the triplet state quantum yield [27,30]. 
For the non-halogenated analogues time resolution was not possible due to low phosphorescence 
emission.  
 The optimized structures of the BDP 1 and BDP 2 are shown in Figure 3. The BODIPYs 
were optimized to a stationary point on the Born-Oppenheimer potential energy surface of the 












arrangement. Similar arrangement was determined in BDP 1-H
+
 and BDP 2-H
+
 protonated 
molecules (Figure S3). Electronic density calculations for BDP 1 and BDP 2 (Figure 3) indicated 
that the HOMO was positioned on the BODIPY core and the LUMO was also located in the s-
indacene ring. Therefore, according to the theoretical calculations for these compounds the lowest-
lying state S0 → S1 excitation is almost completely associated with the HOMO/LUMO transition of 
the -system [11,26]. This behavior is also expected in their protonated forms (Figure S3). 
Moreover, to evaluate the behavior of these BODIPYs after excitation with visible light, energy of 
HOMO and LUMO levels of exited state of BODIPY core and grown state of benzene derivatives 
were calculated (Figure S4). It was found that PeT process can take place from the 
dimethylaminopropoxybenzyl group towards brominated BODIPY unit but protonation of the 
amine group can avoid this process. Furthermore, charge distribution BDP 1-H
+
 and BDP 2-H
+
 
protonated forms were slight affected in the excited singlet state respect to ground state, with the 
positive charge in the ammonium group localized at the end of the carbon chain (Figure 1). 
 
3.3. Photosensitized generation of O2(
1g) 
 Aerobic photooxidation reaction of DMA induced by BDP 1 and BDP 2 was evaluated in 
ACN. The decrease in the concentration of DMA due to generation of endoperoxide was 
determined by reducing the absorbance at max = 378 nm (Figure S5) [31]. Furthermore, the 
absorbance of the BODIPYs did not change after irradiation during the experiments, indicating a 
high photostability under these experimental conditions. Figure 4 shows characteristic plots that 
describe the consumption of DMA as the photooxidation reaction proceeds. Data plotted of ln A0/A 
vs time are linear from which kobs
DMA
 can be determined. These results are gathered in Table 1. The 
photooxidation rate of DMA mediated by BDP 1 was considerably lower (33-fold) than that 
sensitized by BDP 2. 
From the kinetic data of DMA decomposition, the value of  was determined in ACN, 














chemical reaction. Therefore, DMA can be used to specifically detect and quantified the presence of 
this ROS [31]. Thus, values of  were calculated by comparing the kobs
DMA
 (Table 1) for both 
BODIPYs with that for the reference. According with this approach, very low production of O2(
1
g) 
was detected using BDP 1 as PS [15,27]. In contrast, the effect of heavy atom in BDP 2 induced the 
formation of O2(
1
g) with similar value to those reported before for brominates BODIPYs [14,19]. 
 





 was evaluated using NBT method with the addition of β-NADH [20]. The 
reaction of O2
•
 with NBT yields the reduction product diformazan, which has an absorption band 
centered at 560 nm. Thus, the aerobic decomposition of NBT sensitized by BDP 1 and BDP 2 were 
studied using β-NADH as reductant in solution of DMF/1% water. The changes in the absorption at 
560 nm as a function of time are shown in Figure 5. A slow reduction of NBT mediated by these 
BODIPYS was observed in the absence of β-NADH. Likewise, a slight decomposition of NBT was 
found in presence of β-NADH without the BODIPYs. In contrast, the reaction of NBT increased 
when BDP 1 or BDP 2 and β-NADH were added in comparison with the solution without the 
BODIPY. In both cases, β-NADH was necessary for photosensitized generation of diformazan. The 
formation of O2
•
 was higher for the reaction photoinduced by BDP 1 than BDP 2. The ability of 
several related BODIPYs to generate O2
•
 was previously reported [27]. The formation of O2
•
 was 
more efficient for an unsubstituted BODIPY than for its brominated analog and even less for 
iodinated, in reverse order of O2(
1
g) production. In the case of BDP 1, the photodynamic action 
mainly involves the generation O2
•
 using β-NADH as reductant, while BDP 2 exerts its action by 
forming O2(
1
g) by a type II mechanism, according with the heavy atom effect. 
 
3.5. Uptake of BODIPYs by bacteria 
The capability of BDP 1 and BDP 2 to be incorporate by bacterial cells was studied in S. 












and 1.0 M) in the dark at 37 °C. Figure 6 shows the amount of BODIPY recovered from bacterial 
cells after different incubation time (2, 5, 15 and 30 min). The highest binding values of BDP 1 and 
BDP 2 to microbial cells were quickly reached after 2 min of incubation. Furthermore, the amount 
of cell-bound BODIPY was not significantly changed incubating the bacterial cells for longer times 
(30 min). In S. aureus, the amount of recovered BODIPY was slightly higher for BDP 1 than BDP 
2, while a similar uptake was found in E. coli. When S. aureus cells were incubated with 1.0 M, an 
average value of 0.60 nmol/10
8
 cells was obtained for BDP 1, while the uptake was 0.54 nmol/10
8
 
cells for BDP 2 (Figure 6A). In E. coli, the binding of both BODIPYs reached 0.51 nmol/10
8
 cells 
(Figure 6B). In both bacterial strains, the number of molecules was reduced by approximately half 
when cultures were incubated with 0.5 M of the BODIPYs. Therefore, non-saturation occurs over 
this concentration range. These results specify a high interaction between both BODIPYs and the 
pathogens. The presence of a positively charged precursor group allows a fast-cellular uptake in 
only 2 min of treatment. As already shown, cationic molecules can interact better with negatively 
charged components present in the cell wall. Comparable results were previously found with 
cationic BODIPYs bound to S. aureus and E. coli cells [16]. Moreover, this behavior was 
previously observed in the uptake of BODIPYs by bacteria [21]. In the present results for both 
bacteria, the cell-bound PS was similar, being slightly higher for BDP 1 than BDP 2 in S. aureus. 
The efficacy of PDI can be significantly influenced by the uptake of PSs by bacterial cells [32]. In 
Gram-negative bacteria, the outer membrane (OM) acts as a barrier to prevent the interaction of 
ROS with vital target components. The presence of lipopolysaccharides in OM affords a density of 
negative charges on bacteria. This anionic cell surface avoids the uptake of neutral and anionic PSs. 
Hence, combination in the PS structure of cationic groups with an amphiphilic character can be 
required for an effective inactivation of Gram-negative bacteria [18]. 
 To obtain evidence on the cellular imaging of bacteria, fluorescence microscopy was used to 
evaluate the uptake of BDP 1 and BDP 2 by cells following a similar procedure previously 












a closed chamber. During this period, cells can attach to the glass surface thanks to its pilus. Then, 
planktonic microbes are eliminated by washing, remaining only those that were anchored to the 
glass. For the uptake experiments, 1 M of the corresponding BODIPY in PBS was added in the 
chamber and fluorescence images were monitored as a function of time. A fast binding of BODIPY 
to either S. aureus or E. coli was found observing the green fluorescence emission of the bacterial 
cells. This is illustrated in Figure 7A for bacteria treated with BDP 1. As can be observed, emission 
in the green channel corresponding to BDP1 was detected for both bacteria indicating the uptake of 
this BODIPY. The fluorescent images were also noticed in cells treated with BDP 2 (Figure 7B). 
However, a considerably less intense emission was found for cells treated with the brominated 
BODIPY. This fact coincides with the lower ΦF of BDP 2 than BDP 1, attributed to fluorescence 
quenching due to the heavy atom effect that promotes intersystem crossing. Similar results were 
previously reported for cationic BODIPYs bound to microbial cells [16]. The emission shown 
mainly by BDP 1 in the biological environment indicates that this compound has interesting 
characteristics to be used as a fluorophore for cell diagnostic images. 
 
3.6. PDI of bacteria 
 The photodynamic activity sensitized by BDP 1 and BDP 2 was evaluated for in vitro 
inactivation of S. aureus and E. coli cells. Several strains of S. aureus have developed resistance to 
multiple drugs due to adaptation to different antibiotics, with few possible therapies available for 
their treatment [33]. Furthermore, this microbe has been described as the main human pathogen that 
causes hospital-acquired infections [3]. For PDI studies, S. aureus cell suspensions were incubated 
with both BODIPYs at different concentrations, 0.5 and 1.0 M, for 30 min in the dark at 37 °C. 
The therapy started upon irradiation with visible light. The viability of S. aureus cells after different 
irradiation times are shown in Figure 8A. Control tests showed that the viability of S. aureus was 
not affected by irradiation of the cells without PS (Figure 8A) or by dark incubation of bacteria with 












cells treated with PS and irradiated was produced by the photosensitization effect of BODIPYs. As 
shown in Figure 8A, photokilling of S. aureus cells was dependent on BODIPY concentrations and 
irradiation times. A lower S. aureus inactivation was found for cells treated with 1 M BDP 1, 
reaching 0.5 log and 2.8 log reduction in bacterial survival after 5 min and 15 min light irradiation, 
respectively. In contrast, cell survival was rapidly decreased for bacteria incubated with BDP 2 and 
exposed to visible light. Thus, bacterial suspensions treated with 0.5 M BDP 2 produced 4.5 log 
decrease in viability with only 2 min of irradiation. Furthermore, no colony formation was found 
after an exposure of 15 min, indicating that this PS was very effective at concentrations as low as 
nanomolar. When 1.0 M BDP 2 was used, complete eradication of S. aureus was obtained after 5 
min irradiation. Therefore, BDP 2 showed an outstanding inactivation at short irradiation times and 
low concentrations. PDI mediated by BDP 2 can be compared with other PSs using under similar 
conditions. Structurally related non-brominated cationic BODIPYs were investigated against S. 
aureus [16]. These PSs inactivated 4 log at 1.0 M BODIPY after illumination with visible light for 
5 min but using a cell density of 1x10
7
 CFU/mL. Similar results were obtained with a porphyrin and 
its chlorin analog substituted by four dimethylaminopropoxy groups using 1.0 M PS and 5 min 
irradiation [17]. With the same conditions, comparable photokilling was also obtained in the 
presence of a bacteriochlorin bearing two spermine units [34]. 
On the other hand, PDI studies with BDP 1 and BDP 2 were performed in E. coli microbial 
cells. This Gram-negative bacterium was selected due to the increased antibiotic resistance of E. 
coli cells that have produced a substantial increase in serious infection diseases and considerable 
spending on public health care [35,36]. Therefore, E. coli cells were treated with BODIPYs, using 
different concentrations of 0.5, 1.0 and 5.0 M, for 30 min in the dark at 37 °C. After that, bacterial 
cells were irradiated for different times (5, 15 and 30 min). The survival curves of E. coli are shown 
in Figure 8B. Control experiments indicates that the viability of E. coli was not modified by 
irradiation of cells alone (Figure 8B) or by incubation with PSs in the dark for 30 min (Figure S6B). 












can be seen in Figure 8B, the PDI results indicated that BDP 1 was less active than BDP 2 to 
photoinactivate E. coli. After 30 min irradiation, it was found a reduction of 1.6 log and 5 log when 
the cells were treated with 1 M and 5 M BDP 1, respectively. On the other hand, bacterial 
suspensions treated with 1.0 M BDP 2 and irradiated for 5 min produced 4 log decrease in 
viability, while 15 min irradiation exhibited a photosensitizing activity of 6 log units. These results 
indicate a cellular inactivation greater than 99.9999%. After 30 min light, bacteria were eradicated 
and cell viability was not detected. When 5.0 M BDP 2 was used, with only 15 min of irradiation 
the E. coli cells were eliminated. Furthermore, PDI experiments were also tested with 0.5 M BDP 
2 (Figure S7). Using this low concentration, it was possible to achieve inactivation of 4.5 log 
(99.997% photokilling) after exposure to visible light of 30 min, demonstrating the high 
effectiveness of this BODIPY. In previous studies, cationic BODIPYs without bromine atoms were 
little effective to inactivate E. coli [16]. Under similar conditions, a cationic BODIPY contains a 
N,N,N-trimethylamino group attached to the phenylene unit was able to produce a reduction of 2 
log, when the cells were treated with 5 M and 15 min irradiation. Similar result was also obtained 
with a BODIPY unsubstituted by methyl groups at the s-indacene ring and bearing a cationic 
dimethylaminopropoxy substituent. These non-brominated BODIPYs achieved 4.5 log decrease in 
E. coli survival after 30 min irradiation. The photokilling capacity of these BODIPYs was 
potentiated by the addition of potassium iodine. Moreover, BDP 2 has shown to be more effective 
than other PS such as chlorins or porphyrins containing up to four basic amino groups in the 
periphery to inactivate the same bacterial strain [17]. It was even more effective than a 
bacteriochlorin substituted by eight aliphatic amine groups [34]. In addition, it was established that 
a porphyrin substituted by dimethylaminopropoxy groups without intrinsic charges was equally 
active as its analogous cationic porphyrin in photo-inactivating microorganisms [37,38]. Therefore, 
the presence of a precursor group of positive charge should be considered to design effective 












Comparing cell photoinactivation, S. aureus was more susceptible than the E. coli to the 
photodynamic effect sensitized by BDP 1 and BDP 2. This different behavior between the two 
strains can be understood taking into account the structural characteristics of the cell envelope. The 
cell wall of Gram-positive bacteria is made of multiple layers of peptidoglycan that contain 
lipoteichoic and teichoic acids [39]. This structural organization gives permeability to the bacterial 
wall, which facilitates the binding of PS, increasing its photodynamic action that inactivates S. 
aureus [40]. The presence of the OM in Gram-negative bacteria that is located outside the 
peptidoglycan layer presents an asymmetric lipid structure formed by negatively charged 
lipopolysaccharides (LPS), lipoproteins and proteins with porin function. Consequently, the OM 
acts as an effective barrier that is relatively impermeable to neutral or anionic agents. Therefore, 
PSs substituted by cationic charge precursor groups, such as BDP 2, can interact effectively with 




In this work, we presented the synthesis of two new BODIPY derivatives (BDP 1 and BDP 
2) containing a dimethylaminopropoxy group attached to the phenylene unit at the meso-position of 
the s-indacene ring. Both BODIPYs absorb intensively in the central region of the visible spectrum. 
In solution, BDP 1 was characterized by an intense green fluorescence emission, very low O2(
1
g) 
production and appreciable ability to form generation O2
•
 in presence of β-NADH as reductant. In 
contrast, brominated BDP 2 showed a low emission of fluorescence with an increased formation of 
O2(
1
g) and less capacity to form O2
•
 than BDP 1. Therefore, the photodynamic activity sensitized 
by BDP 2 involves mainly a type II photoprocess, while in BDP 1 prevails a pathway type I. 
Binding of these BDIPYs to bacterial cells was rapid, reaching a maximum value at short 
incubation times. Moreover, BDP 1 showed interesting properties as fluorescent probe for imaging 












2 and 5 min irradiation. Furthermore, a higher photokilling was found in E. coli after irradiation for 
15 min. Therefore, BDP 2 completes the main requirements as a phototherapeutic agent to be used 
in PDI, such as a short binding time, low concentrations, and short irradiation periods. These 
BODIPYs contain a dimethylaminopropoxy and its protonation in water allows to increase the 
binding to the bacterial cells. Moreover, the effect of heavy atom in BDP2 led to an enhance in the 
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BDP 1 497 9.1 x 10
4
 506 2.47 0.85  0.02 (5.45  0.05) x 10
-5
 0.014  0.005 
BDP 2 522 8.9 x 10
4
 537 2.34 0.24  0.01 (1.81  0.02) x 10
-3
 0.51  0.02 
a






 fluorescence quantum yield using H2B-OAc as a 
reference [19], 
c
 observed rate constants for the photooxidation reaction of DMA, 
d
 quantum yield 
of O2(
1
g) production using Br2B-OAc as a reference kobs
ACN



















Figures and Schemes captions 
Figure 1. The structures optimized by DFT / TD-DFT and the ESP surfaces of the BDP 1 and BDP 
2 molecules and their protonated forms (BDP 1-H
+
 and BDP 2-H
+
). The negative ESP regions was 
shown in red and the positive regions in blue. 
 
Figure 2. (A) Absorption spectra and (B) fluorescence emission spectra (exc = 480 nm) of BDP 1 
(dashed line) and BDP 2 (solid line) in ACN. 
 
Figure 3. Optimized structure, highest occupied molecular orbital (HOMO) and lowest unoccupied 
molecular orbital (LUMO) of the BDP 1 and BDP 2 molecules. All calculations were performed by 
DFT at the B3LYP/6-31+G(d) level using Gaussian 09. 
 
Figure 4. First-order plots for the photodecomposition of DMA (35 M) photosensitized by BDP 1 
(), BDP 2 () and Br2B-OAc () in ACN; irr = 506 nm. 
 
Figure 5. Time course of NBT (0.2 mM) reduction to diformazan photosensitized by BDP 1 () 
and BDP 2 () in presence of β-NADH (0.5 mM); λirr = 506 nm. Controls: NBT+β-NADH (), 
BDP1 + NBT (), BDP 2 + NBT (). 
 
Figure 6. Amount of BODIPY recovered from (A) S. aureus (~10
8
 CFU/mL) treated with 0.5 M 
BDP 1 (), 1.0 M BDP 1 (), 0.5 M BDP 2 (), 1.0 M BDP 2 () for different incubation 
times at 37 ºC in dark. 
 
Figure 7. Bright field images (left) and fluorescence emission images (right) for S. aureus (top) and 
E. coli (bottom) cells incubated with 1 μM (A) BDP 1 and (B) BDP2 for 30 min at 37 °C in the 













Figure 8. Survival curves of (A) S. aureus (~10
8
 CFU/mL) incubated with 0.5 M () and 1.0 M 
() of BDP 1 and 0.5 M () and 1.0 M () of BDP 2 and (B) E. coli (~10
8
 CFU/mL) incubated 
with 1.0 M () and 5.0 M () of BDP 1 and 1.0 M () and 5.0 M () of BDP 2 for 30 min at 
37 °C in the dark. Samples were irradiated for different periods with visible light. Control cells 
untreated with PS and irradiated (). 
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BODIPY derivatives are a promising molecular architecture for use as a broad-spectrum 
antimicrobial photosensitizer. The presence of a basic amine group in the BODIPY structure allows a 
better binding to bacterial cells, leading to a highly effective photoinactivation. This molecular design 
















 New BODIPYs containing a dimethylaminopropoxy group were synthesized. 
 The basic aliphatic amino group provides effective binding to bacterial cells. 
 The highly fluorescent BODIPY is an interesting fluorophore for bioimaging. 
 Brominated BODIPY was highly effective to eradicate bacteria at low concentrations. 
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